Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Finasteride may cause kidney damage.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Finasteride may cause slight depression and anxiety.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

SHBG may be a useful early indicator and treatment target for PCOS.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Androgens may block hair growth signals, targeting this could treat hair loss.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.